Search

Your search keyword '"Geiger, Tamar"' showing total 628 results

Search Constraints

Start Over You searched for: Author "Geiger, Tamar" Remove constraint Author: "Geiger, Tamar"
628 results on '"Geiger, Tamar"'

Search Results

1. Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy

Catalog

Books, media, physical & digital resources

4. PDZD8 interacts with Protrudin and Rab7 at ER-late endosome membrane contact sites associated with mitochondria.

8. Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors

9. Disrupted neural correlates of anesthesia and sleep reveal early circuit dysfunctions in Alzheimer models

10. IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy

13. Distinct extracellular–matrix remodeling events precede symptoms of inflammation

15. Spatiotemporal Proteomic Analysis of Stress Granule Disassembly Using APEX Reveals Regulation by SUMOylation and Links to ALS Pathogenesis

17. Anti-tumour immunity induces aberrant peptide presentation in melanoma

19. Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence

23. UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive Tumors

24. p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells

27. Supplementary Figure 8 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

28. Supplementary Figure 3 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

29. Supplementary Figure 2 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

30. Supplementary Figure 5 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

31. Supplementary Figure 4 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

32. Supplementary Figure 1 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

37. IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer

38. Table S4 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

39. Supplementary Figure Legends from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

40. Data from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

41. Supplementary Figure 6 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

42. Supplementary Figure 7 from MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2

43. Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short‐term vs long‐term survivors of glioblastoma

44. MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2